Compare ALSN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALSN | ICLR |
|---|---|---|
| Founded | 1915 | 1990 |
| Country | United States | Ireland |
| Employees | 4000 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.2B |
| IPO Year | 2011 | 2001 |
| Metric | ALSN | ICLR |
|---|---|---|
| Price | $135.53 | $100.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $117.57 | ★ $178.62 |
| AVG Volume (30 Days) | 595.9K | ★ 921.1K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.33 | N/A |
| Revenue | ★ $3,010,000,000.00 | N/A |
| Revenue This Year | $94.98 | N/A |
| Revenue Next Year | $5.30 | N/A |
| P/E Ratio | $18.51 | ★ $12.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $76.01 | $66.57 |
| 52 Week High | $136.89 | $211.00 |
| Indicator | ALSN | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 72.54 | 39.03 |
| Support Level | $110.01 | $95.75 |
| Resistance Level | N/A | $114.75 |
| Average True Range (ATR) | 3.02 | 4.91 |
| MACD | 1.01 | -0.33 |
| Stochastic Oscillator | 93.20 | 9.91 |
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.